The Central Core Laboratory in the Department of Pathology consists of the Immunopathology, Cytogenetic and Molecular Pathology laboratories. The Immunopathology Laboratory (directed by Dr. F. Behm), has been dedicated to the processing immunophenotyping, cryopreserving and distribution of samples from patients with leukemia for over 12 years. Two full-time technologists supported by this grant perform the following activities: isolation of leukemic/mononuclear cells from patient samples for distribution to the institution's researchers; sample preparation for immunophenotyping and DNA Index determination; cell banking of cryopreserved leukemic and remission samples; and maintenance of the LEUCEL computer data base. The cytogenetics laboratory directed by Dr. S.
R aim ondi, karyotypes leukemic and remission samples by classic methodologies and by the technique of fluorescence in situ hybridization (FISH). Molecular Pathology, directed by Dr. J. Downing, performs molecular diagnostic and investigative studies of leukemic and remission samples using contemporary molecular biological techniques. The combined studies performed in these laboratories are required for (i) characterization of samples placed in the Cell Bank, (ii) detection of minimal residual disease in remission and bone marrow transplant patients as outlined in the section entitled Clinical Core D, (iii) direct support for projects 1, 2, 3, and 5.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA020180-19
Application #
5206934
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
19
Fiscal Year
1996
Total Cost
Indirect Cost
Pieters, Rob; Hunger, Stephen P; Boos, Joachim et al. (2011) L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase. Cancer 117:238-49
Kaste, Sue C (2011) Imaging pediatric bone sarcomas. Radiol Clin North Am 49:749-65, vi-vii
Kaste, Sue C; Waszilycsak, George L; McCarville, M Beth et al. (2010) Estimation of potential excess cancer incidence in pediatric 201Tl imaging. AJR Am J Roentgenol 194:245-9
Kaste, S C; Thomas, N A; Rai, S N et al. (2009) Asymptomatic kidney stones in long-term survivors of childhood acute lymphoblastic leukemia. Leukemia 23:104-8
Kaste, Sue C; Metzger, Monika L; Minhas, Anum et al. (2009) Pediatric Hodgkin lymphoma survivors at negligible risk for significant bone mineral density deficits. Pediatr Blood Cancer 52:516-21
Marchese, Victoria G; Connolly, Barbara H; Able, Colleen et al. (2008) Relationships among severity of osteonecrosis, pain, range of motion, and functional mobility in children, adolescents, and young adults with acute lymphoblastic leukemia. Phys Ther 88:341-50
Rai, Shesh N; Hudson, Melissa M; McCammon, Elizabeth et al. (2008) Implementing an intervention to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia: BONEII, a prospective placebo-controlled double-blind randomized interventional longitudinal study design. Contemp Clin Trials 29:711-9
Martin, Mary Beth; Li, Chin-Shang; Rowland, Christopher C et al. (2008) Correlation of bone age, dental age, and chronological age in survivors of childhood acute lymphoblastic leukaemia. Int J Paediatr Dent 18:217-23
Kaste, Sue C; Ahn, Hyunah; Liu, Tiebin et al. (2008) Bone mineral density deficits in pediatric patients treated for sarcoma. Pediatr Blood Cancer 50:1032-8
Kaste, Sue C (2008) Skeletal toxicities of treatment in children with cancer. Pediatr Blood Cancer 50:469-73;discussion 486

Showing the most recent 10 out of 613 publications